GENEA WRAGG: Open Payments
NPI 1588296156 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 16 payments from 9 companies in 2025. Trend: 2023 $681 · 2024 $325 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $165 |
| Biogen, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $124 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Hologic Sales and Service, LLC | 2 | $38 |
| Sage Therapeutics, LLC | 2 | $31 |
| OptumHealth Care Solutions, LLC | 1 | $24 |
| MILLICENT US INC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: ZURZUVAE, Veozah, ANNOVERA, ACCRUFER, APTIMA, VIVIFY HEALTH CARE TEAM PORTAL 001, FEMLYV, Qelbree.
Industry payments across NV — which companies pay providers there.
